Efficacy of 186Re-HEDP in Patients with Painful Bone Metastases
| Pain response | n |
| Complete response | 9 (47.4%) |
| Partial response | 4 (21.1%) |
| Minimal response | 2 (10.5%) |
| No response | 4 (21.1%) |
| Duration of response | |
| <4 wk | 6 (21.1%) |
| 4–8 wk | 2 (10.5%) |
| ≥8 wk | 7 (36.8%) |
| Flare response | |
| Yes | 12 (63.2%) |
| No | 7 (36.8%) |